My Treatment Approach: Metastatic Castration-Resistant Prostate Cancer - Episode 2

Approved Treatment Options for Patients with mCRPC

April 17, 2023

Andrew J. Armstrong, MD, Matthew Manning, MD

Medical oncologist Andrew Armstrong, MD, details the available treatment options for patients with mCRPC, and how recommendations vary by prior therapy and mutation status.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: The Evolution of Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Now Viewing

EP. 2: Approved Treatment Options for Patients with mCRPC

EP. 3: Patient Profile: A 78-Year-Old Man with mCRPC

EP. 4: Treatment Approaches for Patients with mCRPC and Bone-Only Disease Progression After Radiotherapy

EP. 5: Patient Profile: A 72-Year-Old Man with mCRPC and Multiple Bone Metastases

EP. 6: Safety and Efficacy Data on Radium-223 for the Palliative Treatment of mCRPC

EP. 7: Considerations for Treatment Selection for Patients with Disease Progression on Radium-223

EP. 8: Patient Profile: A 67-Year-Old Man with mCRPC and Asymptomatic Bone Metastases

EP. 9: Symptomatic Status and Lesion Size of Bone Metastases: Impact on Radiotherapy Selection in mCRPC

EP. 10: Closing Thoughts on the Future of mCRPC Treatment